12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Tuesday's pre-market session, 12 health care stocks experienced significant price movements. Gainers included FWBI, YS, IBIO, SILO, PTE, and DERM, while losers were ZJYL, BIOR, LABP, NXTC, AIH, and AXDX.
June 13, 2023 | 1:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
First Wave BioPharma's stock rose 136.5% to $2.7 during Tuesday's pre-market session, with a market cap of $5.2 million.
The significant increase in FWBI's stock price during the pre-market session indicates a positive short-term impact on the stock. The 136.5% increase is likely to attract investor attention and potentially drive further price increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
YS Biopharma Co's shares rose 41.93% to $1.76 during Tuesday's pre-market session, with a market value of $163.7 million.
YS Biopharma's 41.93% increase in share price during the pre-market session indicates a positive short-term impact on the stock. The significant rise in price is likely to attract investor attention and potentially drive further price increases.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Biora Therapeutics' shares decreased by 17.98% to $5.11 during Tuesday's pre-market session, with a market cap of $60.5 million.
The 17.98% decrease in Biora Therapeutics' share price during the pre-market session indicates a negative short-term impact on the stock. The significant drop in price is likely to deter investor interest and potentially drive further price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Jin Medical International's shares fell 20.1% to $10.55 during Tuesday's pre-market session, with a market cap of $81.7 million.
The 20.1% decrease in Jin Medical International's share price during the pre-market session indicates a negative short-term impact on the stock. The significant drop in price is likely to deter investor interest and potentially drive further price declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100